Sterigenics Appoints CEO

Michael B. Petras, Jr. has been appointed chief executive officer of Sterigenics International, effective June 20, 2016.  Mr. Petras succeeds Michael Mulhern, who has been appointed to serve as executive chairman of the Sterigenics board of directors.

Mr. Petras has more than 25 years of leadership experience, most recently serving as president of Cardinal Health’s Post-Acute Solutions businesses. Prior to that he was chief executive officer for AssuraMed, a medical products supplier, which Cardinal Health acquired for approximately $2 billion in 2013.  He also worked at General Electric for more than two decades, including serving as president and chief executive officer at GE Lighting and Industrial. Mr. Petras also serves on The Cleveland Clinic’s board of directors.

“Michael Petras is a highly regarded leader with significant experience in both the medical products and services industry, as well as broad-based industrials from his time at GE.  He is ideally suited to lead Sterigenics,” said Jim Neary, board director, Sterigenics, and managing director and member of the Executive Management Group, Warburg Pincus.